Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Vincristine × Clear all

Sponsor

Conditions

Lymphoma 71 Precursor Cell Lymphoblastic Leukemia-Lymphoma 66 Lymphoma, Large B-Cell, Diffuse 52 Lymphoma, Non-Hodgkin 33 Leukemia 33 Burkitt Lymphoma 33 Lymphoma, Mantle-Cell 20 Lymphoma, Follicular 19 Recurrence 13 Lymphoma, B-Cell 13 Hodgkin Disease 13 Neoplasms 11 Lymphoma, Large-Cell, Anaplastic 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Sarcoma 9 Neuroblastoma 8 Multiple Myeloma 8 Medulloblastoma 8 Lymphoma, T-Cell, Peripheral 8 Lymphoma, T-Cell 7 Central Nervous System Neoplasms 7 Rhabdomyosarcoma 6 Leukemia, Biphenotypic, Acute 6 Lymphoma, B-Cell, Marginal Zone 5 Wilms Tumor 4 Waldenstrom Macroglobulinemia 4 Sarcoma, Ewing 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Lymphoma, Large-Cell, Immunoblastic 4

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 pembrolizumab 1 ioflupane 1 idelalisib 1 aflibercept 1 Water 1 Vertical Dimension 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡